Related references
Note: Only part of the references are listed.miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2
Shatovisha Dey et al.
MOLECULAR CANCER RESEARCH (2020)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Shuo Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma
Jingwen Zhang et al.
LABORATORY INVESTIGATION (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
Ian J. Purvis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway
Ku-Chung Chen et al.
PLOS ONE (2019)
1 A Systematic Review of miR-29 in Cancer
Jason J. Kwon et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
B7-H3 in tumors: friend or foe for tumor immunity?
Gen Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer
Luz Garcia-Alonso et al.
CANCER RESEARCH (2018)
MYC: Master Regulator of Immune Privilege
Stephanie C. Casey et al.
TRENDS IN IMMUNOLOGY (2017)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Senbabaoglu et al.
GENOME BIOLOGY (2016)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response
Jung-Tsu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
Wei Zhang et al.
ONCOTARGETS AND THERAPY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT
D-W Wu et al.
ONCOGENE (2015)
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
M. K. Nygren et al.
BRITISH JOURNAL OF CANCER (2014)
B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
Jinhua Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
被撤回的出版物: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas (Retracted article. See vol. 41, pg. 1198, 2023)
Xinwei Zhang et al.
CANCER CELL (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
Hong Xu et al.
CANCER RESEARCH (2009)
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion
Yih-Wen Chen et al.
CURRENT CANCER DRUG TARGETS (2008)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
WK Suh et al.
NATURE IMMUNOLOGY (2003)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
